Cited by 180Dementia and Cognitive Impairment ResearchAdvanced Neuroimaging Techniques and ApplicationsAlzheimer's disease research and treatments

Brain microstructure reveals early abnormalities more than two years prior to clinical progression from mild cognitive impairment to Alzheimer's disease

Open access
Douaud, Gwenaëlle, Menke, Ricarda A. L., Gass, Achim, Monsch, Andreas U., Rao, Anil, Whitcher, Brandon, Zamboni, Giovanna, Matthews, Paul M. +2 more·2013·The Journal of Neuroscience

Abstract

Diffusion imaging is a promising marker of microstructural damage in neurodegenerative disorders, but interpretation of its relationship with underlying neuropathology can be complex. Here, we examined both volumetric and brain microstructure abnormalities in 13 amnestic patients with mild cognitive impairment (MCI), who progressed to probable Alzheimer's disease (AD) no earlier than 2 years after baseline scanning, in order to focus on early, and hence more sensitive, imaging markers. We compared them to 22 stable amnestic MCI patients with similar cognitive performance and episodic memory impairment but who did not show progression of symptoms for at least 3 years. Significant group differences were mainly found in the volume and microstructure of the left hippocampus, while white matter group differences were also found in the body of the fornix, left fimbria, and superior longitudinal fasciculus (SLF). Diffusion index abnormalities in the SLF were the sign of a subtle microstructural injury not detected by standard atrophy measures in the corresponding gray matter regions. The microstructural measure obtained in the left hippocampus using diffusion imaging showed the most substantial differences between the two groups and was the best single predictor of future progression to AD. An optimal prediction model (91% accuracy, 85% sensitivity, 96% specificity) was obtained by combining MRI measures and CSF protein biomarkers. These results highlight the benefit of using the information of brain microstructural damage, in addition to traditional gray matter volume, to detect early, subtle abnormalities in MCI prior to clinical progression to probable AD and, in combination with CSF markers, to accurately predict such progression.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.4437-12.2013

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Most studies using diffusion tensor imaging data of healthy older and Alzheimer's disease participants did not consider partial volume effects at all.

    “However, most of the studies using DTI data of healthy older and AD participants did not consider PVE at all (Cherubini et al., 2010, Douaud et al., 2013, Eustache et al., 2016, Müller et al., 2007).”

    From Mean diffusivity in cortical gray matter in Alzheimer's disease: The importance of partial volume correction (2018) · cites this paper as Douaud et al., 2013

    In Materials and Methods (page unavailable), Douaud et al. explicitly identify partial-voluming bias as a pitfall of their grey-matter diffusion analysis and say they kept that caveat in mind. The paper therefore cannot serve as an example of a study that did not consider partial volume effects at all; it also does not establish what most other studies did. (LLM, conf=0.84)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Previous studies reported increases of mean diffusivity in mild cognitive impairment patients that converted to Alzheimer's disease compared to mild cognitive impairment subjects that remained stable over several years.

    “as well as in MCI patients that converted to AD compared to MCI subjects that remained stable over a period of several years (Douaud et al., 2013, Fellgiebel et al., 2006, Scola et al., 2010, van Uden et al., 2016).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 46

  1. Amunts K Kedo O Kindler M Pieperhoff P Mohlberg H Shah NJ Habel U Schneider F Zilles K Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: intersubject variability and probability maps Anat Embryol (Berl) 2005 210 343 352 16208455
  2. Cairns NJ Chadwick A Luthert PJ Lantos PL Astrocytosis, beta A4-protein deposition and paired helical filament formation in Alzheimer's disease Journal of the neurological sciences 1992 112 68 75 1469442
  3. Costafreda SG Dinov ID Tu Z Shi Y Liu CY Kloszewska I Mecocci P Soininen H Tsolaki M Vellas B Wahlund LO Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment NeuroImage 2011 56 212 219 21272654 PMC3066277
  4. Davatzikos C Bhatt P Shaw LM Batmanghelich KN Trojanowski JQ Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification Neurobiology of aging 2011 32 2322 e2319 2327 PMC2951483 20594615
  5. Desikan RS Cabral HJ Hess CP Dillon WP Glastonbury CM Weiner MW Schmansky NJ Greve DN Salat DH Buckner RL Fischl B Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease Brain: a journal of neurology 2009 132 2048 2057 19460794 PMC2714061
  6. Douaud G Smith S Jenkinson M Behrens T Johansen-Berg H Vickers J James S Voets N Watkins K Matthews PM James A Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia Brain 2007 130 2375 2386 17698497
  7. Duchesnay E Roche A Riviere D Papadopoulos D Cointepas Y Mangin JE Population classification based on structural morphometry of cortical sulci 2004 2nd Ieee International Symposium on Biomedical Imaging: Macro to Nano, Vols 1 and 2 2004 1267 1270
  8. Ennis DB Kindlmann G Orthogonal tensor invariants and the analysis of diffusion tensor magnetic resonance images Magn Reson Med 2006 55 136 146 16342267
  9. Ewers M Walsh C Trojanowski JQ Shaw LM Petersen RC Jack CR Jr Feldman HH Bokde AL Alexander GE Scheltens P Vellas B Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance Neurobiology of aging 2012 33 1203 1214 21159408 PMC3328615
  10. Fellgiebel A Dellani PR Greverus D Scheurich A Stoeter P Muller MJ Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus Psychiatry research 2006 146 283 287 16530394
  11. Ferreira LK Diniz BS Forlenza OV Busatto GF Zanetti MV Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM studies Neurobiology of aging 2011 32 1733 1741 20005012
  12. Friston K Ten ironic rules for non-statistical reviewers NeuroImage 2012 61 1300 1310 22521475
  13. Ganguli M Mild cognitive impairment and the 7 uses of epidemiology Alzheimer Dis Assoc Disord 2006 20 S52 57 16917196
  14. Gauthier S Reisberg B Zaudig M Petersen RC Ritchie K Broich K Belleville S Brodaty H Bennett D Chertkow H Cummings JL Mild cognitive impairment Lancet 2006 367 1262 1270 16631882
  15. Greicius MD Srivastava G Reiss AL Menon V Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI Proceedings of the National Academy of Sciences of the United States of America 2004 101 4637 4642 15070770 PMC384799
  16. Haller S Nguyen D Rodriguez C Emch J Gold G Bartsch A Lovblad KO Giannakopoulos P Individual prediction of cognitive decline in mild cognitive impairment using support vector machine-based analysis of diffusion tensor imaging data Journal of Alzheimer's disease: JAD 2010 22 315 327 20847435
  17. Hoeft F Barnea-Goraly N Haas BW Golarai G Ng D Mills D Korenberg J Bellugi U Galaburda A Reiss AL More is not always better: increased fractional anisotropy of superior longitudinal fasciculus associated with poor visuospatial abilities in Williams syndrome The Journal of neuroscience: the official journal of the Society for Neuroscience 2007 27 11960 11965 17978036 PMC6673356
  18. Jack CR Jr Knopman DS Jagust WJ Shaw LM Aisen PS Weiner MW Petersen RC Trojanowski JQ Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade Lancet neurology 2010 9 119 128 20083042 PMC2819840
  19. Kantarci K Petersen RC Boeve BF Knopman DS Weigand SD O'Brien PC Shiung MM Smith GE Ivnik RJ Tangalos EG Jack CR Jr DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment Neurology 2005 64 902 904 15753434 PMC2771335
  20. Lustig C Snyder AZ Bhakta M O'Brien KC McAvoy M Raichle ME Morris JC Buckner RL Functional deactivations: change with age and dementia of the Alzheimer type Proceedings of the National Academy of Sciences of the United States of America 2003 100 14504 14509 14608034 PMC283621
  21. Maioli F Coveri M Pagni P Chiandetti C Marchetti C Ciarrocchi R Ruggero C Nativio V Onesti A D'Anastasio C Pedone V Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit Arch Gerontol Geriatr 2007 44 Suppl 1 233 241 17317458
  22. Makris N Kennedy DN McInerney S Sorensen AG Wang R Caviness VS Jr Pandya DN Segmentation of subcomponents within the superior longitudinal fascicle in humans: a quantitative, in vivo, DT-MRI study Cereb Cortex 2005 15 854 869 15590909
  23. McKhann G Drachman D Folstein M Katzman R Price D Stadlan EM Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 1984 34 939 944 6610841
  24. Mesulam MM From sensation to cognition Brain: a journal of neurology 1998 121 Pt 6 1013 1052 9648540
  25. Mielke MM Kozauer NA Chan KC George M Toroney J Zerrate M Bandeen-Roche K Wang MC Vanzijl P Pekar JJ Mori S Regionally-specific diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease NeuroImage 2009 46 47 55 19457371 PMC2688089
  26. Miller G Alzheimer's research. Stopping Alzheimer's before it starts Science (New York, N Y) 2012 337 790 792 22903991
  27. Minoshima S Giordani B Berent S Frey KA Foster NL Kuhl DE Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease Annals of neurology 1997 42 85 94 9225689
  28. Misra C Fan Y Davatzikos C Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI NeuroImage 2009 44 1415 1422 19027862 PMC2648825
  29. Mueller SG Weiner MW Thal LJ Petersen RC Jack CR Jagust W Trojanowski JQ Toga AW Beckett L Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI) Alzheimer's & dementia: the journal of the Alzheimer's Association 2005 1 55 66 PMC1864941 17476317
  30. Oishi K Akhter K Mielke M Ceritoglu C Zhang J Jiang H Li X Younes L Miller MI van Zijl PC Albert M Multi-modal MRI analysis with disease-specific spatial filtering: initial testing to predict mild cognitive impairment patients who convert to Alzheimer's disease Front Neurol 2011 2 54 21904533 PMC3160749
  31. Petersen RC Early diagnosis of Alzheimer's disease: is MCI too late? Curr Alzheimer Res 2009 6 324 330 19689230 PMC3098139
  32. Pike CJ Cummings BJ Monzavi R Cotman CW Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease Neuroscience 1994 63 517 531 7891862
  33. Santillo AF Gambini JP Lannfelt L Langstrom B Ulla-Marja L Kilander L Engler H In vivo imaging of astrocytosis in Alzheimer's disease: an (1)(1)C-L-deuteriodeprenyl and PIB PET study Eur J Nucl Med Mol Imaging 2011 38 2202 2208 21853308
  34. Schroeter ML Stein T Maslowski N Neumann J Neural correlates of Alzheimer's disease and mild cognitive impairment: a systematic and quantitative meta-analysis involving 1351 patients NeuroImage 2009 47 1196 1206 19463961 PMC2730171
  35. Selkoe DJ The molecular pathology of Alzheimer's disease Neuron 1991 6 487 498 1673054
  36. Smith SM Jenkinson M Johansen-Berg H Rueckert D Nichols TE Mackay CE Watkins KE Ciccarelli O Cader MZ Matthews PM Behrens TE Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data NeuroImage 2006 31 1487 1505 16624579
  37. Steele ML Robinson SR Reactive astrocytes give neurons less support: implications for Alzheimer's disease Neurobiology of aging 2010 21051108
  38. Teipel SJ Born C Ewers M Bokde AL Reiser MF Moller HJ Hampel H Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment NeuroImage 2007 38 13 24 17827035
  39. Thomas AG Koumellis P Dineen RA The fornix in health and disease: an imaging review Radiographics 2011 31 1107 1121 21768242
  40. Tondelli M Wilcock GK Nichelli P De Jager CA Jenkinson M Zamboni G Structural MRI changes detectable up to ten years before clinical Alzheimer's disease Neurobiology of aging 2011 21782287
  41. Trachtenberg AJ Filippini N Mackay CE The effects of APOE-epsilon4 on the BOLD response Neurobiology of aging 2010 20409610
  42. Van Camp N Blockx I Camon L de Vera N Verhoye M Veraart J Van Hecke W Martinez E Soria G Sijbers J Planas AM A complementary diffusion tensor imaging (DTI)-histological study in a model of Huntington's disease Neurobiology of aging 2010 20724035
  43. Vemuri P Wiste HJ Weigand SD Shaw LM Trojanowski JQ Weiner MW Knopman DS Petersen RC Jack CR Jr MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change Neurology 2009 73 294 301 19636049 PMC2715214
  44. Whitwell JL Shiung MM Przybelski SA Weigand SD Knopman DS Boeve BF Petersen RC Jack CR Jr MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment Neurology 2008 70 512 520 17898323 PMC2734138
  45. Winblad B Palmer K Kivipelto M Jelic V Fratiglioni L Wahlund LO Nordberg A Backman L Albert M Almkvist O Arai H Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment J Intern Med 2004 256 240 246 15324367
  46. Zhuang L Wen W Zhu W Trollor J Kochan N Crawford J Reppermund S Brodaty H Sachdev P White matter integrity in mild cognitive impairment: a tract-based spatial statistics study NeuroImage 2010 53 16 25 20595067

Cited by

Sorted by citations

Authors
Douaud, G., Menke, R. A. L., Gass, A., Monsch, A. U., Rao, A., Whitcher, B., Zamboni, G., Matthews, P. M., Sollberger, M., & Smith, S.
Affiliations
  • University of Oxford (GB)
  • Warneford Hospital (GB)
  • University Hospital of Basel (CH)
  • Imperial College London (GB)
  • Hammersmith Hospital (GB)
Venue
The Journal of Neuroscience
Published
2013-01-30
Volume
33
Issue
5
Pages
2147-2155
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2077357661
Cited by
180
References
16
Citations by year
2026: 2 · 2025: 10 · 2024: 10 · 2023: 11 · 2022: 10 · 2021: 7 · 2020: 18 · 2019: 19 · 2018: 14 · 2017: 18 · 2016: 17 · 2015: 16 · 2014: 20 · 2013: 8
FWCI
14.46
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by-nc-sa)
Funders
  • GlaxoSmithKline
  • Universität Basel
  • Wellcome Trust (098369)
  • National Institute for Health and Care Research
  • Parkinson's UK (J-0901)
  • Engineering and Physical Sciences Research Council (EP/F05727X/1)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced Neuroimaging Techniques and Applications
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
mild cognitive impairment, Alzheimer's disease, progression prediction, brain microstructure, diffusion imaging, hippocampus, white matter microstructure, superior longitudinal fasciculus, fornix, fimbria, cerebrospinal fluid biomarkers, neurodegeneration, episodic memory
MeSH terms
Aged, Alzheimer Disease, Amnesia, Atrophy, Brain, Female, Humans, Image Processing, Computer-Assisted, Magnetic Resonance Imaging, Male, Middle Aged, Neuropsychological Tests, Peptide Fragments, Phosphorylation, Predictive Value of Tests, Sensitivity and Specificity, Amyloid beta-Peptides, tau Proteins, Disease Progression, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review